Japan’s approach to breast cancer screening is entering a significant new phase after the Health Ministry revealed in June that recipients of municipal breast cancer screenings would begin receiving information about whether they have dense breast tissue, according to a recent report by The Japan Times.
The move addresses an issue that has been debated in Japan for years: women with dense breasts may face a greater chance that a cancer is difficult to spot on a mammogram because both dense tissue and many tumors can appear white on the image.
But while the policy could improve awareness and encourage more informed conversations between patients and doctors, breast density remains one of the most complex issues in cancer screening — and experts worldwide do not agree on whether dense tissue alone should trigger additional tests.
What Is Breast Density — and Why Does It Matter?
Breast density is not about how breasts look or feel. It refers to the proportion of fibrous and glandular tissue compared with fatty tissue as seen on a mammogram.
Dense breast tissue can make mammograms harder to interpret, potentially masking cancers. The American College of Radiology’s latest guidance notes that mammography is less sensitive in women with dense breast tissue and says supplemental screening may be considered based on a person’s overall cancer risk and breast density.
That distinction is crucial: having dense breasts does not mean a woman has breast cancer, and it does not automatically mean she needs an MRI or ultrasound.
The decision depends on a broader picture that may include family history, genetic risk, age and other individual factors.
Why Japan’s Change Is Being Closely Watched
The planned notification policy could mark an important shift toward giving women more information about the limitations of their screening results.
Japan has previously been criticized for lagging behind efforts in some other countries to make breast-density information routinely available to patients. The issue is particularly relevant in Japan, where dense breast tissue has long been recognized as a challenge for mammography screening.
The Japanese Breast Cancer Society’s 2022 clinical practice guidelines also reflect an evolving debate. They recommend handheld ultrasound as an adjunct to mammography for population-based breast cancer screening, while advising against ultrasound alone. The guideline cites evidence from Japan’s J-START trial showing more Stage I cancers were detected in the group receiving combined screening and fewer intermediate-stage cancers were observed.
However, more detection does not automatically settle every question about population-wide screening. Additional tests can also lead to false positives, unnecessary follow-up procedures and anxiety — one reason health authorities must carefully balance benefits and harms.
The Global Debate: More Information, But No Simple Answer
Japan is not alone in grappling with the question of what should happen after a woman is told she has dense breasts.
A 2024 systematic review of breast-screening guidelines found substantial disagreement internationally. Of 23 guidelines examined, some recommended supplemental screening for women with dense breasts, while roughly one-third did not recommend it. Ultrasound was the most commonly suggested additional test among guidelines that supported supplemental screening, but MRI, tomosynthesis and contrast-enhanced mammography were also used in some recommendations.
The American College of Obstetricians and Gynecologists, meanwhile, does not recommend routine alternative or additional screening solely because an asymptomatic person has dense breasts and no other risk factors, citing insufficient evidence of a clear overall benefit and concerns about false positives.
The takeaway is clear: breast density is important information, but it is not a diagnosis and should not be interpreted in isolation.
What Should Women Do If Their Screening Says They Have Dense Breasts?
For women who receive a dense-breast notification, the most useful next step is not panic — it is an informed discussion with a healthcare professional.
Questions worth asking include:
- What does my breast density mean for the accuracy of my mammogram?
- Do I have other factors that increase my risk of breast cancer?
- Would additional screening be appropriate in my individual case?
- What are the potential benefits and risks of ultrasound, MRI or other tests?
The Japanese government’s screening discussions have already formally examined how the national program should respond to high-density breasts, underscoring how seriously policymakers are taking the issue.
A Long-Overdue Step — But Not the Final Answer
Japan’s decision to provide breast-density information could empower more women to understand an important limitation of mammography and have better conversations about their personal screening options.
Yet notification alone will not solve the larger challenge. The medical community is still working to determine which women benefit most from additional imaging, how to avoid unnecessary procedures and how to ensure that better information leads to better outcomes rather than greater confusion.
For now, Japan’s message is changing: a “normal” mammogram may not tell every woman the same story — and knowing what breast density means could become an increasingly important part of understanding that story.
Leave a Reply